Fluroxene toxicity induced by phenobarbital.
Because of reports of fluroxene toxicity in man, the effect of phenobarbital treatment on the toxicity and metabolism of fluroxene was studied in 9 rhesus monkeys. Six monkeys that were exposed to a mean calculated alveolar fluroxene concentration of 5.8% for 4-hr periods up to a total of 16 hr showed no evidence of toxicity. Two animals were sacrificed after a single 4-hr exposure to obtain control measures of fluroxene metabolites in tissues. Four monkeys that had previously survived received exposures to fluroxene and 3 monkeys that had no exposure to fluroxene died during fluroxene anesthesia after treatment with phenobarbital (mean time, 3 hr). Toxicity was manifested by arterial hypotension, pulmonary edema, and arterial hypoxemia. Phenobarbital treatment enhanced production of fluroxene metabolites, including the highly toxic trifluoroethanol. Concentrations of trifluoroethanol in mixed-expired gas, blood, and urine, and of total nonvolatile fluorine in blood, urine, and tissues of animals treated with phenobarbital were 2 to 10 times as in control animals. The results suggest that the rhesus monkey is a valuable model for the study of fluroxene pharmacology and that inclusion of an enzyme-inducing challenge in the evaluation of potential toxicity of other anesthetics seems warranted.
D000758:Anesthesia; D000818:Animals; D004987:Ethers / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D005459:Fluorides / Q000378:metabolism; D005461:Fluorine / Q000378:metabolism; D000882:Haplorhini; D008168:Lung / Q000473:pathology; D008253:Macaca mulatta; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology*; D013997:Time Factors
D004987:Ethers; D005461:Fluorine; D005459:Fluorides; D010634:Phenobarbital